• Unicycive Therapeutics has drawn heightened market attention after a sharp share-price decline that placed it among notable biotech decliners.
• Universe Pharmaceuticals has drawn heightened market attention after a notable share-price slide that placed it among the day's pharmaceutical decliners.
• Vince Holding has attracted renewed market attention after a share-price drop that has invited fresh scrutiny from retail investors.
• Virax Biolabs has drawn renewed market attention after a share-price slide that reflects fresh pressure on small-capitalisation biotech names.
• VisionWave Holdings has drawn heightened market attention after a share-price slide that has tested sentiment around this defense-and-advanced-technology name.
• Nexentis Technologies has drawn market attention after a share-price slide that has tested small-cap technology sentiment.
• Orchestra BioMed has drawn heightened market attention following share-price weakness that has placed the clinical-stage biotech under closer investor examination.
• Protara Therapeutics has drawn heightened market attention after a share-price slide that lines up with a fresh check on biotech sentiment.
• Portfolio company MediGuide International launched a new API-first enterprise digital platform.
• Fiscal 2026 net sales were $190.5 million, down 14.3% year over year, or 5.4% when adjusted for prior-year order timing.